SCHEMBL2665809

SCHEMBL2665809

C=C(O)CCNC(=C)c1ccc(CNCc2ccccc2Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
TP53 P04637 1/20 0.40
CYP2C9 P11712 1/20 0.40
RECQL P46063 1/20 0.40
POLB P06746 1/20 0.39
CXCR4 P61073 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2665739 0.78 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2NPSR1KMT2A
SCHEMBL25376216 0.74 ALDH1A1 (0.66) ALDH1A1KDM4ESMN1; SMN2NPSR1KMT2A
SCHEMBL15416895 0.72 ALDH1A1 (0.63) ALDH1A1KDM4ESMN1; SMN2NPSR1KMT2A
SCHEMBL18635939 0.69 KDM4E (0.60) ALDH1A1KDM4ESMN1; SMN2NPSR1KMT2A
SCHEMBL15637983 0.69 SMN1; SMN2 (0.63) ALDH1A1KDM4ESMN1; SMN2NPSR1KMT2A
SCHEMBL6072254 0.69 CHRM2 (0.72) ALDH1A1KDM4EKMT2AMEN1CHRM2
SCHEMBL8160775 0.69 HIF1A (0.53) SMN1; SMN2LMNATP53FFAR1
SCHEMBL19559071 0.68 CHRM2 (0.56) ALDH1A1KDM4EKMT2AMEN1CHRM2
Iodide SCHEMBL9478324 0.67 CHRM2 (0.69) ALDH1A1KDM4EKMT2AMEN1CHRM2
SCHEMBL24181481 0.67 PTGS1 (0.39) ALDH1A1SMN1; SMN2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004002480-A1 NOVEL GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 2004-01-08 WO disclosed